But, in a large-scale cohort study, relative to warfarin, there was a nonsignificant tendency for lower rates of myocardial infarction with dabigatran among vitamin K antagonists (VKA) "new starters" users; however, there was a nonsignificant trend for increased occurrence of myocardial infarction among the prior VKA-experienced users.
1
—
—